Overview

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
to determine the therapeutic roles of CIK cells on patients with psoriasis
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chinese PLA General Hospital